Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial

OBJECTIVES: We conducted a single-blinded, randomized trial to evaluate the safety, reactogenicity, and immunogenicity of heterologous booster vaccination in health care workers (HCW) who had received two doses of ChAdOx1 nCov-19. METHODS: HCW who had at least 90 days after the second dose were enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Chih-Hsien, Huang, Chung-Guei, Huang, Ching-Tai, Chen, Yi-Ching, Kung, Yu-An, Chen, Chih-Jung, Chuang, Tzu-Chun, Liu, Ching-Chi, Huang, Po-Wei, Yang, Shu-Li, Gu, Po-Wen, Shih, Shin-Ru, Chiu, Cheng-Hsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651991/
https://www.ncbi.nlm.nih.gov/pubmed/36399969
http://dx.doi.org/10.1016/j.jcv.2022.105328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651991/
https://www.ncbi.nlm.nih.gov/pubmed/36399969
http://dx.doi.org/10.1016/j.jcv.2022.105328

Ejemplares similares